These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1900427)

  • 1. Swainsonine stimulation of the proliferation and colony forming activity of murine bone marrow.
    White SL; Nagai T; Akiyama SK; Reeves EJ; Grzegorzewski K; Olden K
    Cancer Commun; 1991 Mar; 3(3):83-91. PubMed ID: 1900427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of swainsonine on murine survival and bone marrow proliferation during cytotoxic chemotherapy.
    Oredipe OA; White SL; Grzegorzewski K; Gause BL; Cha JK; Miles VA; Olden K
    J Natl Cancer Inst; 1991 Aug; 83(16):1149-56. PubMed ID: 1909378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced proliferation of functionally competent bone marrow cells in different strains of mice treated with swainsonine.
    Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; White SL; Olden K; Parish-Gause D; Vaughn T; Griffin WM; Sridhar R
    Int Immunopharmacol; 2003 Mar; 3(3):445-55. PubMed ID: 12639822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limits of stimulation of proliferation and differentiation of bone marrow cells of mice treated with swainsonine.
    Oredipe OA; Furbert-Harris PM; Laniyan I; Griffin WM; Sridhar R
    Int Immunopharmacol; 2003 Oct; 3(10-11):1537-47. PubMed ID: 12946451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of macrophage tumoricidal activity, major histocompatibility complex class II antigen (Iak) expression, and interleukin-1 production by swainsonine.
    Grzegorzewski K; Newton SA; Akiyama SK; Sharrow S; Olden K; White SL
    Cancer Commun; 1989; 1(6):373-9. PubMed ID: 2484638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swainsonine stimulates bone marrow cell proliferation and differentiation in different strains of inbred mice.
    Oredipe OA; Furbert-Harris PM; Green WR; White SL; Olden K; Laniyan I; Parish-Gause D; Vaughn T; Griffin WM; Sridhar R
    Pharmacol Res; 2003 Jan; 47(1):69-74. PubMed ID: 12526864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swainsonine modulation of protein kinase C activity in murine peritoneal macrophages.
    Breton P; Asseffa A; Grzegorzewski K; Akiyama SK; White SL; Cha JK; Olden K
    Cancer Commun; 1990; 2(10):333-8. PubMed ID: 2119676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swainsonine: an inhibitor of glycoprotein processing.
    Elbein AD; Solf R; Dorling PR; Vosbeck K
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7393-7. PubMed ID: 6801650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential importance of swainsonine in therapy for cancers and immunology.
    Olden K; Breton P; Grzegorzewski K; Yasuda Y; Gause BL; Oredipe OA; Newton SA; White SL
    Pharmacol Ther; 1991; 50(3):285-90. PubMed ID: 1754603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition of human melanoma tumor xenografts in athymic nude mice by swainsonine.
    Dennis JW; Koch K; Yousefi S; VanderElst I
    Cancer Res; 1990 Mar; 50(6):1867-72. PubMed ID: 2106389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of swainsonine and polyinosinic:polycytidylic acid on murine tumor cell growth and metastasis.
    Dennis JW
    Cancer Res; 1986 Oct; 46(10):5131-6. PubMed ID: 3093060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity.
    Klein JL; Roberts JD; George MD; Kurtzberg J; Breton P; Chermann JC; Olden K
    Br J Cancer; 1999 Apr; 80(1-2):87-95. PubMed ID: 10389983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swainsonine induces the production of hybrid glycoproteins and accumulation of oligosaccharides in male reproductive tissues of the rat.
    Tulsiani DR; Skudlarek MD; Orgebin-Crist MC
    Biol Reprod; 1990 Jul; 43(1):130-8. PubMed ID: 2118392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells.
    Humphries MJ; Matsumoto K; White SL; Olden K
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1752-6. PubMed ID: 3081900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of growth of subcutaneous xenografts and metastasis of human breast carcinoma by swainsonine: modulation of tumor cell HLA class I antigens and host immune effector mechanisms.
    Mohla S; White S; Grzegorzewski K; Nielsen D; Dunston G; Dickson L; Cha JK; Asseffa A; Olden K
    Anticancer Res; 1990; 10(6):1515-22. PubMed ID: 2126682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lysosomal alpha-mannosidase by swainsonine, an indolizidine alkaloid isolated from Swainsona canescens.
    Dorling PR; Huxtable CR; Colegate SM
    Biochem J; 1980 Nov; 191(2):649-51. PubMed ID: 6786280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swainsonine: a new antineoplastic immunomodulator.
    Mohla S; Humphries MJ; White SL; Matsumoto K; Newton SA; Sampson CC; Bowen D; Olden K
    J Natl Med Assoc; 1989 Oct; 81(10):1049-56. PubMed ID: 2509720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of DNA synthesis in murine lymphocytes by the drug swainsonine: immunomodulatory properties.
    White SL; Schweitzer K; Humphries MJ; Olden K
    Biochem Biophys Res Commun; 1988 Jan; 150(2):615-25. PubMed ID: 3124836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo induction of gliadin-mediated enterocyte damage in rats by the mannosidase inhibitor, swainsonine: a possible animal model for celiac disease.
    Köttgen E; Beiswenger M; James LF; Bauer C
    Gastroenterology; 1988 Jul; 95(1):100-6. PubMed ID: 3131176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.